DK1257271T3 - Anvendelse af pramipexol til tobaks/nikotinmisbrug - Google Patents

Anvendelse af pramipexol til tobaks/nikotinmisbrug

Info

Publication number: DK1257271T3
Authority: DK; Denmark
Prior art keywords: pramipexole; tobacco; nicotine abuse; nicotine; abuse
Prior art date: 2000-02-23

Application number

DK01906557T

Other languages

English (en)

Inventor

Robert C Marshall

Erik H F Wong

Voigtlander Philip F Von

Original Assignee

Pharmacia & Upjohn Co Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-23

Filing date

2001-02-14

Publication date

2006-08-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22676121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1257271(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-02-14 Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc

2006-08-21 Application granted granted Critical

2006-08-21 Publication of DK1257271T3 publication Critical patent/DK1257271T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Addiction (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicinal Preparation (AREA)

DK01906557T 2000-02-23 2001-02-14 Anvendelse af pramipexol til tobaks/nikotinmisbrug DK1257271T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US18424200P	2000-02-23	2000-02-23

Publications (1)

Publication Number	Publication Date
DK1257271T3 true DK1257271T3 (da)	2006-08-21

Family

ID=22676121

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01906557T DK1257271T3 (da)	2000-02-23	2001-02-14	Anvendelse af pramipexol til tobaks/nikotinmisbrug

Country Status (24)

Country	Link
US (1)	US6410579B2 (da)
EP (1)	EP1257271B1 (da)
JP (1)	JP2003523387A (da)
KR (1)	KR20030016230A (da)
CN (1)	CN1396826A (da)
AR (1)	AR027945A1 (da)
AT (1)	ATE326967T1 (da)
AU (1)	AU781358B2 (da)
BR (1)	BR0107983A (da)
CA (1)	CA2397874A1 (da)
CO (1)	CO5261586A1 (da)
DE (1)	DE60119896T2 (da)
DK (1)	DK1257271T3 (da)
ES (1)	ES2263586T3 (da)
HK (1)	HK1053058A1 (da)
MX (1)	MXPA02008184A (da)
MY (1)	MY127739A (da)
NZ (1)	NZ520974A (da)
PE (1)	PE20011074A1 (da)
PT (1)	PT1257271E (da)
SI (1)	SI1257271T1 (da)
TW (1)	TWI250016B (da)
WO (1)	WO2001062249A1 (da)
ZA (1)	ZA200206119B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10041478A1 (de)	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	Neue pharmazeutische Zusammensetzung
DE10138275A1 (de) *	2001-08-10	2003-02-27	Boehringer Ingelheim Pharma	Verbindungen zur Beseitigung der Anhedonie
AU2002360600B2 (en)	2001-12-11	2007-11-29	University Of Virginia Patent Foundation	Use of pramipexole to treat amyotrophic lateral sclerosis
US20040048779A1 (en) *	2002-05-06	2004-03-11	Erwin Schollmayer	Use of rotigotine for treating the restless leg syndrome
PE20040134A1 (es) *	2002-07-25	2004-03-06	Pharmacia Corp	Forma de dosificacion de una vez al dia de pramipexol
DE10361258A1 (de)	2003-12-24	2005-07-28	Schwarz Pharma Ag	Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
RU2252789C1 (ru) *	2004-01-12	2005-05-27	Семенов Сергей Петрович	Способ первичной психопрофилактики наркомании среди студентов высших учебных заведений
RU2252790C1 (ru) *	2004-01-12	2005-05-27	Семенов Сергей Петрович	Способ первичной психопрофилактики наркомании среди учащихся 13-15 лет
WO2005070428A1 (en) *	2004-01-22	2005-08-04	Boehringer Ingelheim International Gmbh	Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
DE102004014841B4 (de)	2004-03-24	2006-07-06	Schwarz Pharma Ag	Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
UA95993C2 (ru) *	2004-08-13	2011-09-26	Бёрингер Ингельхайм Интернациональ Гмбх	Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
UA86831C2 (uk) *	2004-08-13	2009-05-25	Бьорінгер Інгельхайм Інтернаціональ Гмбх	Композиція таблетки пролонгованого вивільнення, яка містить праміпексол або його фармацевтично прийнятну сіль, спосіб її виготовлення та її застосування
US20070134169A1 (en) *	2005-12-11	2007-06-14	Rabinoff Michael D	Methods for smoking cessation or alcohol cessation or other addiction cessation
US20090041844A1 (en) *	2006-02-10	2009-02-12	Boehringer Ingelheim International Gmbh	Modified Release Formulation
WO2007090883A1 (en) *	2006-02-10	2007-08-16	Boehringer Ingelheim International Gmbh	Extended release formulation
US8518926B2 (en)	2006-04-10	2013-08-27	Knopp Neurosciences, Inc.	Compositions and methods of using (R)-pramipexole
ES2379117T3 (es)	2006-05-16	2012-04-20	Knopp Neurosciences, Inc.	Composiciones de R(+) y S(-) pramipexol y métodos de utilización de las mismas
US8524695B2 (en)	2006-12-14	2013-09-03	Knopp Neurosciences, Inc.	Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
WO2008113056A2 (en)	2007-03-14	2008-09-18	Knopp Neurosciences, Inc.	Synthesis of chirally purified substituted benzothiazole diamines
EP2203448B1 (de) *	2007-09-21	2011-06-22	Sanofi-Aventis	Phenothiazin-derivate mit doppelbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CN102186350A (zh)	2008-08-19	2011-09-14	诺普神经科学股份有限公司	使用(r)-普拉克索的组合物与方法
WO2013096816A1 (en)	2011-12-22	2013-06-27	Biogen Idec Ma Inc.	Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
DE102012108398B4 (de)	2012-09-10	2014-05-22	Schott Ag	Kochfeld, Blende, Geräteeinhausung sowie Kamin- oder Ofensichtscheibe mit einem Hologramm und Verfahren zu dessen bzw. deren Herstellung, sowie Verwendung eines Substrats, auf welchem ein Phasenhologramm aufgebracht ist
US9662313B2 (en)	2013-02-28	2017-05-30	Knopp Biosciences Llc	Compositions and methods for treating amyotrophic lateral sclerosis in responders
SMT202100119T1 (it)	2013-07-12	2021-05-07	Knopp Biosciences Llc	Trattamento dei livelli elevati di eosinofili e/o basofili
US9468630B2 (en)	2013-07-12	2016-10-18	Knopp Biosciences Llc	Compositions and methods for treating conditions related to increased eosinophils
EP3038467B1 (en)	2013-08-13	2020-07-29	Knopp Biosciences LLC	Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
AU2014306597B2 (en)	2013-08-13	2018-05-17	Knopp Biosciences Llc	Compositions and methods for treating chronic urticaria

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE45735T1 (de)	1984-12-22	1989-09-15	Thomae Gmbh Dr K	Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
DE3843227A1 (de)	1988-12-22	1990-07-05	Boehringer Ingelheim Kg	Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) *	1989-09-11	1991-03-21	Boehringer Ingelheim Kg	Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit
DE3933738A1 (de)	1989-10-10	1991-04-11	Boehringer Ingelheim Kg	Neue verwendung von 2-aminothiazol-derivaten (tsh)
DE3937271A1 (de)	1989-11-09	1991-05-16	Boehringer Ingelheim Kg	Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE4241013A1 (de)	1992-12-05	1994-06-09	Boehringer Ingelheim Kg	Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
US5650420A (en)	1994-12-15	1997-07-22	Pharmacia & Upjohn Company	Pramipexole as a neuroprotective agent
US6001861A (en)	1998-01-16	1999-12-14	Pharmacia & Upjohn Company	Use of pramipexole in the treatment of restless legs syndrome
CA2384840A1 (en)	1999-09-30	2001-04-05	The General Hospital Corporation	Use of pramipexole as a treatment for cocaine craving

2001
- 2001-02-07 PE PE2001000131A patent/PE20011074A1/es not_active Application Discontinuation
- 2001-02-09 MY MYPI20010581A patent/MY127739A/en unknown
- 2001-02-14 PT PT01906557T patent/PT1257271E/pt unknown
- 2001-02-14 EP EP01906557A patent/EP1257271B1/en not_active Revoked
- 2001-02-14 BR BR0107983-2A patent/BR0107983A/pt not_active Application Discontinuation
- 2001-02-14 JP JP2001561315A patent/JP2003523387A/ja active Pending
- 2001-02-14 DK DK01906557T patent/DK1257271T3/da active
- 2001-02-14 AU AU34454/01A patent/AU781358B2/en not_active Ceased
- 2001-02-14 SI SI200130592T patent/SI1257271T1/sl unknown
- 2001-02-14 KR KR1020027010951A patent/KR20030016230A/ko not_active Ceased
- 2001-02-14 ES ES01906557T patent/ES2263586T3/es not_active Expired - Lifetime
- 2001-02-14 HK HK03105334.1A patent/HK1053058A1/zh unknown
- 2001-02-14 US US09/783,656 patent/US6410579B2/en not_active Expired - Fee Related
- 2001-02-14 DE DE60119896T patent/DE60119896T2/de not_active Revoked
- 2001-02-14 CN CN01804037A patent/CN1396826A/zh active Pending
- 2001-02-14 CA CA002397874A patent/CA2397874A1/en not_active Abandoned
- 2001-02-14 MX MXPA02008184A patent/MXPA02008184A/es active IP Right Grant
- 2001-02-14 WO PCT/US2001/001232 patent/WO2001062249A1/en not_active Ceased
- 2001-02-14 AT AT01906557T patent/ATE326967T1/de not_active IP Right Cessation
- 2001-02-14 NZ NZ520974A patent/NZ520974A/en unknown
- 2001-02-20 AR ARP010100754A patent/AR027945A1/es unknown
- 2001-02-22 CO CO01014318A patent/CO5261586A1/es not_active Application Discontinuation
- 2001-02-23 TW TW090104177A patent/TWI250016B/zh not_active IP Right Cessation
2002
- 2002-07-31 ZA ZA200206119A patent/ZA200206119B/en unknown

Also Published As

Publication number	Publication date
WO2001062249A1 (en)	2001-08-30
AR027945A1 (es)	2003-04-16
ATE326967T1 (de)	2006-06-15
US20010041727A1 (en)	2001-11-15
CO5261586A1 (es)	2003-03-31
KR20030016230A (ko)	2003-02-26
DE60119896T2 (de)	2006-11-09
SI1257271T1 (sl)	2006-10-31
PT1257271E (pt)	2006-09-29
AU781358B2 (en)	2005-05-19
ES2263586T3 (es)	2006-12-16
MXPA02008184A (es)	2002-11-29
ZA200206119B (en)	2003-10-31
CN1396826A (zh)	2003-02-12
HK1053058A1 (zh)	2003-10-10
AU3445401A (en)	2001-09-03
BR0107983A (pt)	2003-01-28
US6410579B2 (en)	2002-06-25
CA2397874A1 (en)	2001-08-30
EP1257271B1 (en)	2006-05-24
MY127739A (en)	2006-12-29
NZ520974A (en)	2004-04-30
JP2003523387A (ja)	2003-08-05
TWI250016B (en)	2006-03-01
EP1257271A1 (en)	2002-11-20
DE60119896D1 (de)	2006-06-29
PE20011074A1 (es)	2001-10-04

Publication	Publication Date	Title
DK1257271T3 (da)	2006-08-21	Anvendelse af pramipexol til tobaks/nikotinmisbrug
ATE376831T1 (de)	2007-11-15	Nicotin- oder isonicotin benzothiazole derivaten
ATE527901T1 (de)	2011-10-15	Zigarettenfilter
ATE313968T1 (de)	2006-01-15	Tabakverarbeitung
DK1343773T3 (da)	2007-02-05	Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DE60142055D1 (de)	2010-06-17	Temperaturkompensationsoszillator
NO20024742D0 (no)	2002-10-02	Heterocykliske forbindelser, deres fremstilling og anvendelse
ATE258928T1 (de)	2004-02-15	Respiratorisches syncytialvirus replikation inhibitoren
AR028567A1 (es)	2003-05-14	Nuevos derivados de fenil-propargileter
ATE259796T1 (de)	2004-03-15	Respiratorisches syncytialvirus replikation inhibitoren
DK1341779T3 (da)	2006-10-30	Heterocyklisk sulfonamid-inhibitorer af beta-amyloidproduktion
AR028596A1 (es)	2003-05-14	Nuevos derivados de fenilglicina
DK1309545T3 (da)	2007-10-29	Fremgangsmåde til fremstilling af alkylarylsulfonater
DE60126814D1 (de)	2007-04-05	Inhalation von stickoxid
FR2827482B1 (fr)	2003-10-24	Dispositif de capsage de feuilles de tabac
DE50101844D1 (de)	2004-05-06	Filterzigarette
DK1326836T3 (da)	2004-06-01	Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1150681T3 (da)	2006-05-22	Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed
DK1541043T3 (da)	2014-03-17	Filter til cigaret
DK1468996T3 (da)	2008-01-07	Indolderivater til behandling af CNS-sygdomme
DK1294694T3 (da)	2004-12-27	Fremgangsmåde til fremstilling af quinolinderivater
DK1272486T3 (da)	2004-12-06	Fremgangsmåde til fremstilling af 7-(pyrazol-3-yl)benzoxazoler
NO20024887L (no)	2002-10-10	FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser
DK1404341T3 (da)	2007-02-05	Kombination af aktive substanser til farmakologisk terapi af nikotinafhængighed
NO20033163L (no)	2003-07-10	Ny anvendelse av iloperidon